Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warning
- Posted on July 29, 2025
- Drugs (Pharmaceuticals)
- By The New York Times
- 3 Views
Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warning
Novo Nordisk slashed its financial forecasts as it struggled to fight off competition in the United States. It also named a new chief executive, who highlighted the “urgency” of the moment. continue reading...
